BioCentury
ARTICLE | Clinical News

CART-BCMA: Preliminary Ph I data

December 9, 2016 10:08 PM UTC

Preliminary data from 6 evaluable patients with relapsed or refractory MM in an open-label, U.S. Phase I trial showed that IV CART-BCMA over 3 days led to 1 stringent complete response, 1 very good pa...